B Group, Inc. Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$129.9B
Holdings
17
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ADMAADMA BIOLOGICS INC | 2,317,542 | $42.2B | 32.48% | |
| 2 | IM8NINSMED INC | 155,000 | $15.6B | 12.01% | |
| 3 | ZLABZAI LAB LTD | 400,000 | $14.0B | 10.77% | |
| 4 | AKROAKERO THERAPEUTICS INC | 232,446 | $12.4B | 9.55% | |
| 5 | LLYELI LILLY & CO | 15,000 | $11.7B | 9.00% | Put |
| 6 | CLLSCELLECTIS S A | 3,256,501 | $5.0B | 3.82% | |
| 7 | TSHATAYSHA GENE THERAPIES INC | 1,800,556 | $4.2B | 3.20% | |
| 8 | RAREULTRAGENYX PHARMACEUTICAL IN | 110,000 | $4.0B | 3.08% | |
| 9 | SGHTSIGHT SCIENCES INC | 930,000 | $3.8B | 2.96% | |
| 10 | AURAAURA BIOSCIENCES INC | 572,576 | $3.6B | 2.76% | |
| 11 | ASMBASSEMBLY BIOSCIENCES INC | 189,350 | $3.4B | 2.64% | |
| 12 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1,500,000 | $2.6B | 1.99% | |
| 13 | RAREULTRAGENYX PHARMACEUTICAL IN | 67,600 | $2.5B | 1.89% | Call |
| 14 | APGEAPOGEE THERAPEUTICS INC | 35,000 | $1.5B | 1.17% | |
| 15 | PRAXPRAXIS PRECISION MEDICINES I | 35,000 | $1.5B | 1.13% | |
| 16 | SYRESPYRE THERAPEUTICS INC | 80,000 | $1.2B | 0.92% | |
| 17 | ORKAORUKA THERAPEUTICS INC | 75,000 | $840.8M | 0.65% |